切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - ULK1 - MAPKAP-K2 - ALK

14件产品中的 1-10

页面
每页
清除全部
  1. Entrectinib
    B5859 Entrectinib
    中文名: 恩曲替尼
    Target: Trk Receptors|ALK|ROS1
    Summary: ALK激酶抑制剂
      ≥28.05 mg/mL
      insoluble in H2O
  2. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1抑制剂
      ≥24.47 mg/mL
      insoluble in H2O
  3. PF-06463922
    B4882 PF-06463922
    中文名: 劳拉替尼
    Target: ALK|ROS1
    Summary: ALK/ROS1的强效选择性抑制剂
      ≥20.3 mg/mL
      insoluble in H2O
  4. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  5. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  6. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  7. K02288
    B2286 K02288
    Target: ALK
    Summary: ALK抑制剂
      ≥17.6 mg/mL
      insoluble in H2O
  8. AZD-3463
    A8620 AZD-3463
     3 Citation
    Target: ALK|Insulin-like growth factors (IGFs)
    Summary: ALK/IGF1R抑制剂
      ≥11.22 mg/mL
      insoluble in H2O
  9. CH5424802
    A8393 CH5424802
    中文名: 阿来替尼
    Target: ALK
    Summary: ALK的有效ATP竞争性抑制剂
      ≥4.83 mg/mL
      insoluble in H2O
  10. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O

14件产品中的 1-10

页面
每页